Upcoming Studies for Men & Women

» Study Details | Apply for the Study

TAK-062-2001 Treatment of Active Celiac Disease in Subjects Attempting a Gl

Participants are needed for the ILLUMINATE-062 Study, which is looking at the safety and effectiveness of an investigational medication designed to break down gluten in the stomach compared with placebo in those with celiac disease who are on a gluten-free diet. The study will evaluate how well the investigational medication reduces celiac-related symptoms and intestinal damage due to gluten exposure.   Participants who have been diagnosed with celiac, which was confirmed by a biopsy, and have been on a gluten-free diet for at least 12 months are needed. Study-related care is provided at no cost, and a travel stipend may be provided.

» Study Details | Apply for the Study

Prevention of Gluten-Specific T Cell Activation in Subjects with Celiac Dis

The ILLUMINATE-101 clinical research study is evaluating the safety and effectiveness of an investigational medication designed to reduce or eliminate the negative immune response to gluten in adults with celiac disease and participants are needed.

» Study Details | Apply for the Study

Women of Childbearing Potential to Evaluate Contraceptive Efficacy and Safe

A Phase 3, Multicenter, Open-Label, Single Arm Study of MR-100A-01 in Women of Childbearing Potential to Evaluate Contraceptive Efficacy and Safety

» Study Details | Apply for the Study

Combination Therapy in Women with Uterine Fibroids or Endometriosis who are

Study of the Safety and Contraceptive Efficacy of Relugolix Combination Therapy in Women with Uterine Fibroids or Endometriosis who are at Risk for Pregnancy

» Study Details | Apply for the Study

An Open-Label Clinical Validation Study of an Applicator Tampon

An Open-Label Clinical Validation Study of an Applicator Tampon

» Study Details | Apply for the Study

Women with Vulvar and Vaginal Atrophy.

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multiple-Site Study to Evaluate the Therapeutic Equivalence of Estradiol Vaginal Inserts 4 mcg (Teva Pharmaceuticals, Inc.) with IMVEXXY® (estradiol vaginal inserts) (TherapeuticsMD, Inc.) in the Treatment of Dyspareunia in Women with Vulvar and Vaginal Atrophy

» Study Details | Apply for the Study

urinary tract infections (uUTI) in adult women.

oral sulopenem etzadroxil/probenecid tablets (500 mg/500 mg) for the treatment of uncomplicated urinary tract infections (uUTI) in adult women.

» Study Details | Apply for the Study

TREATMENT OF ACUTE UNCOMPLICATED INFLUENZA-LIKE ILLNESS

A PHASE 2B DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY OF THE EFFICACY AND SAFETY OF NORKETOTIFEN IN THE TREATMENT OF ACUTE UNCOMPLICATED INFLUENZA-LIKE ILLNESS (ILI)

» Study Details | Apply for the Study

STUDY TO EVALUATE THE EFFICACY, SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF

STUDY TO EVALUATE THE EFFICACY, SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF A MODIFIED RNA VACCINE AGAINST INFLUENZA COMPARED TO LICENSED INACTIVATED INFLUENZA VACCINE IN HEALTHY ADULTS 18 YEARS OF AGE OR OLDER

» Study Details | Apply for the Study

History of Urinary Tract Infection in the Past 2 Years

Prevention of Invasive Extraintestinal Pathogenic Escherichia coli Disease in Adults Aged 60 Years And Older with a History of Urinary Tract Infection in the Past 2 Years

» Study Details | Apply for the Study